Correction: Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
Saved in:
Format: | Article |
---|---|
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/11/1/e004865corr1.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
by: Xiaomei Li, et al.
Published: (2025-01-01) -
Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)
by: Hiroaki Tanaka, et al.
Published: (2022-06-01) -
FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder
by: Li Ling, et al.
Published: (2022-01-01) -
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial
by: Nicola Robinson, et al.
Published: (2025-01-01) -
Oxford textbook of axial spondyloarthritis
by: Vinod Ravindran
Published: (2017-01-01)